Basic Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4209-4231
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4209
Figure 6
Figure 6 Tzu-Chi cancer-antagonizing & life-protecting II decoction regulates mRNA expression of colonic ZO-1, Occludin, Claudin-1, MUC-2, NF-κB, and IκB-α in H22 tumor mice receiving chemotherapy. A-F: The mRNA expression analysis of ZO-1 (A), Occludin (B), Claudin-1 (C), MUC-2 (D), NF-κB (E), and IκB-α (F). G: Gel electrophoretograms of the amplification products of ZO-1, NF-κB, Occludin, Claudin-1, IκB-α, MUC-2, and β-actin obtained after real-time PCR. Data with error bars are represented as the mean ± SD (n = 6). aP < 0.05 vs NS-Contr; bP < 0.01 vs NS-Contr; cP < 0.05 vs 5-fluorouracil (FU)-Contr; dP < 0.01 vs 5-FU-Contr; eP < 0.05 vs Yangzhengxiaoji capsules, one-way ANOVA. 5-FU: 5-fluorouracil; YZXJ: Yangzhengxiaoji capsules; TCCL-H: High-dose Tzu-Chi cancer-antagonizing & life-protecting II decoction; TCCL-M: Medium-dose Tzu-Chi cancer-antagonizing & life-protecting II decoction; TCCL-L: Low-dose Tzu-Chi cancer-antagonizing & life-protecting II decoction.